Osaic Holdings
AVXL icon

Osaic Holdings’s Anavex Life Sciences AVXL Stock Holding History

Osaic Holdings’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$119K Buy
38,640
+6,905
+22% +$29.9K ﹤0.01% 4552
2025
Q4 		$113K Sell
31,735
-10,678
-25% -$65.4K ﹤0.01% 4609
2025
Q3 		$400K Buy
42,413
+4,900
+13% +$49.7K ﹤0.01% 3613
2025
Q2 		$346K Sell
37,513
-4,355
-10% -$37.2K ﹤0.01% 3469
2025
Q1 		$359K Buy
41,868
+10,386
+33% +$98.1K ﹤0.01% 3155
2024
Q4 		$338K Buy
31,482
+22,698
+258% +$175K ﹤0.01% 3144
2024
Q3 		$49.9K Buy
8,784
+6,446
+276% +$37.2K ﹤0.01% 4755
2024
Q2 		$9.87K Sell
2,338
-10,726
-82% -$43.4K ﹤0.01% 5802
2024
Q1 		$66.5K Sell
13,064
-8,456
-39% -$47.6K ﹤0.01% 4529
2023
Q4 		$200K Buy
21,520
+8,591
+66% +$59.1K ﹤0.01% 3926
2023
Q3 		$84.7K Sell
12,929
-213
-2% -$1.7K ﹤0.01% 4626
2023
Q2 		$107K Sell
13,142
-1,652
-11% -$14.2K ﹤0.01% 4383
2023
Q1 		$127K Sell
14,794
-1,844
-11% -$18.4K ﹤0.01% 4243
2022
Q4 		$154K Buy
16,638
+7,065
+74% +$75.5K ﹤0.01% 4084
2022
Q3 		$99K Sell
9,573
-1,813
-16% -$19.1K ﹤0.01% 4385
2022
Q2 		$114K Sell
11,386
-5,645
-33% -$53.5K ﹤0.01% 4308
2022
Q1 		$294K Sell
17,031
-2,056
-11% -$25.3K ﹤0.01% 3700
2021
Q4 		$330K Sell
19,087
-35,609
-65% -$677K ﹤0.01% 3459
2021
Q3 		$981K Buy
54,696
+22,694
+71% +$452K ﹤0.01% 2363
2021
Q2 		$722K Buy
32,002
+21,857
+215% +$324K ﹤0.01% 2637
2021
Q1 		$152K Buy
10,145
+3,758
+59% +$41K ﹤0.01% 3990
2020
Q4 		$35K Sell
6,387
-3,850
-38% -$20.3K ﹤0.01% 4802
2020
Q3 		$46K Sell
10,237
-2,750
-21% -$11.8K ﹤0.01% 4351
2020
Q2 		$64K Sell
12,987
-450
-3% -$1.7K ﹤0.01% 4008
2020
Q1 		$42K Buy
+13,437
New +$46.8K ﹤0.01% 4090

Other funds holding AVXL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Osaic Holdings's AVXL Position: Q1 2026 in Review

Osaic Holdings increased its Anavex Life Sciences (AVXL) stake by 22% in Q1 2026, buying an estimated $29.9K and bringing the position to 38,640 shares worth $119K. The position accounts for ﹤0.01% of the portfolio, ranked #4552.

Osaic Holdings first reported a position in AVXL in Q1 2020 and has held it in 25 quarters since. The position peaked at $981K in Q3 2021. 190 funds tracked by Wall St. Rank hold AVXL as of Q1 2026.

  • Osaic Holdings held 38,640 shares of Anavex Life Sciences worth $119K as of Q1 2026.
  • Osaic Holdings bought 6,905 Anavex Life Sciences shares in Q1 2026, an estimated $29.9K.
  • Anavex Life Sciences made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #4552 holding.
  • Osaic Holdings first reported a position in Anavex Life Sciences in Q1 2020 and has held it in 25 quarters since.
  • Osaic Holdings's Anavex Life Sciences position peaked at $981K in Q3 2021.
  • 190 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.